TIMOTHY R WRIGHT
CIK 1288245 · Chief Executive Officer · last filed 2024-04-01
TIMOTHY R WRIGHT is a Chief Executive Officer who has filed 29 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for PTIXW, was dated Apr 1, 2024. Across all open-market trades the lifetime net is −$904.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.29M
3
29
-$904.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Protagenic Therapeutics, Inc.\new (PTIXW) Delisted | Director | — | $0.01 | — | $0 | 1 | 2024-04-01 |
| MDXG | Chief Executive Officer | 1,711,324 | $4.26 | $7.29M | -$904.7K | 10 | 2022-06-13 |
| Covidien plc (COV) Delisted | Senior Vice President | 39,903 | — | — | $0 | 16 | 2010-12-03 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-01 | Protagenic Therapeutics, Inc.\new (PTIXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | MDXG | Sell (S) | −112,000 | -$420.0K | EDGAR |
| 2022-04-12 | MDXG | Grant (A) | +602,679 | $2.78M | EDGAR |
| 2022-03-10 | MDXG | Sell (S) | −45,611 | -$221.6K | EDGAR |
| 2022-02-25 | MDXG | Sell (S) | −61,000 | -$263.1K | EDGAR |
| 2021-06-09 | MDXG | Sell (S) | −101,957 | $0 | EDGAR |
| 2021-03-08 | MDXG | Grant (A) | +335,153 | $0 | EDGAR |
| 2021-02-22 | MDXG | Tax (F) | −70,200 | -$688.7K | EDGAR |
| 2020-08-06 | MDXG | Grant (A) | +572,033 | $0 | EDGAR |
| 2020-06-09 | MDXG | Tax (F) | −89,591 | -$313.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.